GSK Investigational Site
Tula 300053
0 studies enrolling now · 2 studies all time
What they study most
Arthritis, Rheumatoid, Multiple Myeloma
Studies at this site
Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
— Running, not enrolling
COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis
— Completed